Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—A Systematic Review
Abstract
1. Introduction
2. Materials and Methods
3. Results
3.1. Histological Findings
3.2. Value of Diagnosis
3.3. Complications of Nerve Biopsy
4. Discussions
Author Contributions
Funding
Conflicts of Interest
References
- Luigetti, M.; Romano, A.; Di Paolantonio, A.; Bisogni, G.; Rossi, S.; Conte, A.; Madia, F.; Sabatelli, M. Pathological Findings in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Single-Center Experience. Brain Sci. 2020, 10, 383. [Google Scholar] [CrossRef] [PubMed]
- Vallat, J.-M.; Sommer, C.; Magy, L. Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol. 2010, 9, 402–412. [Google Scholar] [CrossRef]
- Dyck, P.J.; Lais, A.C.; Ohta, M.; Bastron, J.A.; Okazaki, H.; Groover, R.V. Chronic inflammatory polyradiculoneuropathy. Mayo Clin. Proc. 1975, 50, 621. [Google Scholar] [PubMed]
- Doneddu, P.E.; Cocito, D.; Manganelli, F.; Fazio, R.; Briani, C.; Filosto, M.; Benedetti, L.; Mazzeo, A.; Marfia, G.A.; Cortese, A.; et al. Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database. J. Neurol. Neurosurg. Psychiatry 2018, 90, 125–132. [Google Scholar] [CrossRef]
- Bunschoten, C.; Jacobs, B.C.; Van den Bergh, P.Y.; Cornblath, D.R.; van Doorn, P.A. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculeuropathy. Lancet Neurol 2019, 18, 784. [Google Scholar] [CrossRef]
- Hughes, R.A.C.; Allen, D.; Makowska, A.; Gregson, N.A. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 2006, 11, 30–46. [Google Scholar] [CrossRef]
- van Schaik, I.N.; Eftimov, F.; van Doorn, P.A.; Brusse, E.; van den Berg, L.H.; Van der Pol, W.L.; Faber, C.G.; van Oostrom, J.C.; Vogels, O.J.; Hadden, R.D.; et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): A double-blind, randomised, controlled trial. Lancet Neurol. 2010, 9, 245–253. [Google Scholar] [CrossRef]
- Thaisetthawatkul, P.; Logigian, E.L.; Herrmann, D.N. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002, 59, 1526–1532. [Google Scholar] [CrossRef]
- Prineas, J.W. Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study. Acta Neuropathol. 1971, 18, 34–57. [Google Scholar] [CrossRef]
- Van den Bergh, P.Y.; van Doorn, P.A.; Hadden, R.D.; Avau, B.; Vankrunkelsven, P.; Allen, J.A.; Attarian, S.; Blomkwist-Markens, P.H.; Cornblath, D.R.; Eftimov, F.; et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Eur. J. Neurol. 2021, 26, 242–268. [Google Scholar]
- Tackenberg, B.; Lunemann, J.D.; Steinbrecher, A.; Rothenfusser-Korber, E.; Sailer, M.; Bruck, W.; Schock, S.; Zschenderlein, R.; Zipp, F.; Sommer, N. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology 2007, 68, 1622–1629. [Google Scholar] [CrossRef] [PubMed]
- Rajabally, Y.A.; Nicolas, G.; Pieret, F.; Bouche, P.; Bergh, P.Y.K.V.D. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: A multicentre European study. J. Neurol. Neurosurg. Psychiatry 2009, 80, 1364–1368. [Google Scholar] [CrossRef] [PubMed]
- Breiner, A.; Brannagan, T.H., III. Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2014, 50, 40–46. [Google Scholar] [CrossRef]
- Molenaar, D.S.M.; Vermeulen, M.; De Haan, R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J. Neurol. Neurosurg. Psychiatry 1998, 64, 84–89. [Google Scholar] [CrossRef] [PubMed]
- Vital, A.; Lagueny, A.; Julien, J.; Ferrer, X.; Barat, M.; Hermosilla, E.; Rouanet-Larrivière, M.; Henry, P.; Bredin, A.; Louiset, P.; et al. Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: A peripheral nerve biopsy study in 18 cases. Acta Neuropathol. 2000, 100, 63–68. [Google Scholar] [CrossRef] [PubMed]
- Haq, R.U.; Fries, T.J.; Pendlebury, W.W.; Kenny, M.J.; Badger, G.J.; Tandan, R. Chronic Inflammatory Demyelinating PolyradiculoneuropathyA Study of Proposed Electrodiagnostic and Histologic Criteria. Arch. Neurol. 2000, 57, 1745–1750. [Google Scholar] [CrossRef] [PubMed]
- Bosboom, W.M.J.; Van den Berg, L.H.; Franssen, H.; Giesbergen, P.C.L.M.; Flach, H.Z.; Van Putten, A.M.; Veldman, H.; Wokke, J.H.J. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 2001, 124 Pt 12, 2427–2438. [Google Scholar] [CrossRef]
- Vallat, J.M.; Tabaraud, F.; Magy, L.; Torny, F.; Bernet-Bernady, P.; Macian, F.; Couratier, P. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: Evaluation of eight cases. Muscle Nerve 2003, 27, 478–485. [Google Scholar] [CrossRef]
- Boukhris, S.; Magy, L.; Kabore, R.; Mabrouk, T.; Li, Y.; Sindou, P.; Tabaraud, F.; Vallat, J.M. Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP)—diagnosis confirmed by nerve biopsy. Neurophysiol. Clin. 2004, 34, 71–79. [Google Scholar] [CrossRef]
- Sommer, C.; Koch, S.; Lammens, M.; Gabreëls-Festen, A.A.W.M.; Stoll, G.; Toyka, K.V. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology 2005, 65, 1924–1929. [Google Scholar] [CrossRef]
- Hilton, D.A.; Jacob, J.; Househam, L.; Tengah, C. Complications following sural and peroneal nerve biopsies. J. Neurol. Neurosurg. Psychiatry 2007, 78, 1271–1272. [Google Scholar] [CrossRef] [PubMed]
- Sommer, C.L.; Brandner, S.; Dyck, P.J.; Harati, Y.; LaCroix, C.; Lammens, M.; Magy, L.; Mellgren, S.I.; Morbin, M.; Navarro, C.; et al. Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies. J. Peripher. Nerv. Syst. 2010, 15, 164–175. [Google Scholar] [CrossRef]
- Kulkarni, G.B.; Mahadevan, A.; Taly, A.B.; Nalini, A.; Shankar, S.K. Shankar Sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy: Are supportive pathologic criteria useful in diagnosis? Neurol. India 2010, 58, 542–548. [Google Scholar] [PubMed]
- Mathis, S.; Magy, L.; Diallo, L.; Boukhris, S.; Vallat, J.M. Amyloid Neuropathy Mimiking Chronic Inflammatory Demyelinating Polyneuropathy. Muscle Nerve 2012, 45, 26–31. [Google Scholar] [CrossRef] [PubMed]
- Peltier, A.C.; Donofrio, P.D. Chronic Inflammatory Demyelinating Polyradiculoneuropathy: From Bench to Bedside. Semin Neurol. 2012, 32, 187–195. [Google Scholar]
- Mathey, E.K.; Park, S.B.; Hughes, R.A.; Pollard, J.D.; Armati, P.J.; Barnett, M.H.; Taylor, B.V.; Dyck, P.J.B.; Kiernan, M.C.; Lin, C.S. Chronic inflammatory demyelinating polyradiculoneuropathy: From pathology to phenotype. J. Neurol. Neurosurg. Psychiatry 2015, 86, 973–985. [Google Scholar] [CrossRef]
- Allen, J.A.; Gorson, K.C.; Gelinas, D. Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy. Brain Behav. 2018, 8, e00932. [Google Scholar] [CrossRef]
- Xu, M.; Pinto, M.; Sun, C.; Engelstad, J.K.; Dyck, P.J.; Dyck, P.J.; Klein, C.J. Expanded teased nerve fibre pathological conditions in disease association. J. Neurol. Neurosurg. Psychiatry 2018, 90, 138–140. [Google Scholar] [CrossRef]
- Berini, S.E.; Dyck, P.J.B. The utility of nerve biopsy in carefully selected patients in modern neuromuscular practice. Muscle Nerve 2019, 59, 635–637. [Google Scholar] [CrossRef]
- Nathani, D.; Spies, J.; Barnett, M.H.; Pollard, J.; Wang, M.X.; Sommer, C.; Kiernan, M.C. Nerve biopsy: Current indications and decision tools. Muscle Nerve 2021, 64, 125–139. [Google Scholar] [CrossRef]
- Ikeda, S.; Koike, H.; Nishi, R.; Kawagashira, Y.; Iijima, M.; Katsuno, M.; Sobue, G. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy. J. Neurol. Neurosurg. Psychiatry 2019, 90, 988–996. [Google Scholar] [CrossRef] [PubMed]
- Eftimov, F.; Lucke, I.M.; Querol, L.A.; Rajabally, Y.A.; Verhamme, C. Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain 2020, 143, 3214–3224. [Google Scholar] [CrossRef] [PubMed]
- Stino, A.M.; Naddaf, E.; Dyck, P.J.; Dyck, P.J.B. Chronic inflammatory demyelinating polyradiculoneuropathy—Diagnostic pitfalls and treatment approach. Muscle Nerve 2020, 63, 157–169. [Google Scholar] [CrossRef]
- Jann, S.; Bramerio, M.A.; Beretta, S.; Koch, S.; Defanti, C.A.; Toyka, K.V.; Sommer, C. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. Neurology 2003, 61, 1607–1610. [Google Scholar] [CrossRef] [PubMed]
- Cornblath, D.R.; Asbury, A.K.; Albers, J.W.; Feasby, T.E. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991, 41, 617–618. [Google Scholar]
- Vallat, J.; Magy, L.; Richard, L.; Sturtz, F.; Couratier, P. Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia. Micron 2008, 39, 61–70. [Google Scholar] [CrossRef]
- Matsumuro, K.; Izumo, S.; Umehara, F.; Osame, M. Chronic inflammatory demyelinating polyneuropathy: Histological and immunopathological studies on biopsied sural nerves. J. Neurol. Sci. 1994, 127, 170–178. [Google Scholar] [CrossRef]
- Bouchard, C.; Lacroix, C.; Plante, V.; Adams, D.; Chedru, F.; Guglielmi, J.M.; Said, G. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999, 52, 498–503. [Google Scholar] [CrossRef]
- Uncini, A.; De Angelis, M.V.; Di Muzio, A.; Callegarini, C.; Ciucci, G.; Antonini, G.; Lugaresi, A.; Gambi, D. Chronic inflammatory demyelinating polyneuropathy in diabetics: Motor conductions are important in the differential diagnosis with diabetic polyneuropathy. Clin. Neurophysiol. 1999, 110, 705–711. [Google Scholar] [CrossRef]
- Midroni, G.; Bilbao, J.M. Biopsy Diagnosis of Peripheral Neuropathy; Butterworth-Heinemann: Boston, MA, USA, 1995; p. 45. [Google Scholar] [CrossRef]
- Barohn, R.J.; Kissel, J.T.; Warmolts, J.R.; Mendell, J.R. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch. Neurol. 1989, 46, 878–884. [Google Scholar] [CrossRef]
- Deprez, M.; Groote, C.C.-D.; Gollogly, L.; Reznik, M.; Martin, J. Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul. Disord. 2000, 10, 92–98. [Google Scholar] [CrossRef]
- Viala, K.; Maisonobe, T.; Stojkovic, T.; Koutlidis, R.; Ayrignac, X.; Musset, L.; Fournier, E.; Léger, J.-M.; Bouche, P. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 2010, 15, 50–56. [Google Scholar] [CrossRef] [PubMed]
- Allen, J.A.; Ney, J.; Lewis, R.A. Electrodiagnostic errors contribute to chronic inflammatory demyelinating polyneuropathy misdiagnosis. Muscle Nerve 2018, 57, 542–549. [Google Scholar] [CrossRef] [PubMed]
- Pollock, M.; Nukada, H.; Taylor, P.; Donaldson, I.; Carroll, G. Comparison between fascicular and whole sural nerve biopsy. Ann. Neurol. 1983, 13, 65–68. [Google Scholar] [CrossRef] [PubMed]
- Said, G. Indications and usefulness of nerve biopsy. Arch. Neurol. 2002, 59, 1532–1535. [Google Scholar] [CrossRef]
- Schoeller, T.; Huemer, G.M.; Shafighi, M.; Gurunluoglu, R.; Wechselberger, G.; Piza-Katzer, H. Microsurgical Repair of the Sural Nerve after Nerve Biopsy to Avoid Associated Sensory Morbidity: A Preliminary Report. Neurosurgery 2004, 54, 897–901. [Google Scholar] [CrossRef]
- Neundörfer, B.; Grahmann, F.; Engelhardt, A.; Harte, U. Postoperative effects and value of sural nerve biopsies: A retrospective study. Eur. Neurol. 1990, 30, 350–352. [Google Scholar] [CrossRef]
- Dahlin, L.B.; Eriksson, K.-F.; Sundkvist, G. Persistent Postoperative Complaints after Whole Sural Nerve Biopsies in Diabetic and Non-diabetic Subjects. Diabet. Med. 1997, 14, 353–356. [Google Scholar] [CrossRef]
- Flachenecker, P.; Janka, M.; Goldbrunner, R.; Toyka, K.V. Clinical outcome of sural nerve biopsy: A retrospective study. J. Neurol. 1999, 246, 93–96. [Google Scholar] [CrossRef]
- Perry, J.R.; Bril, V. Complications of sural nerve biopsy in diabetic versus nondiabetic patients. Can. J. Neurol. Sci. 1994, 21, 34–37. [Google Scholar] [CrossRef][Green Version]
- Ruth, A.; Schulmeyer, F.J.; Roesch, M.; Woertgen, C.; Brawanski, A. Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy. Clin. Neurol. Neurosurg. 2004, 107, 214–217. [Google Scholar] [CrossRef]
- Kumar, S.; Jacob, J. Variability in the extent of sensory deficit after sural nerve biopsy. Neurol. India 2004, 52, 436–438. [Google Scholar]
- Gabriel, C.M.; Howard, R.; Kinsella, N.; Lucas, S.; McColl, I.; Saldanha, G.; Hall, S.M.; Hughes, R.A.C. Prospective study of the usefulness of sural nerve biopsy. J. Neurol. Neurosurg. Psychiatry 2000, 69, 442–446. [Google Scholar] [CrossRef] [PubMed]
- Patwa, H.S.; Chaudhry, V.; Katzberg, H.; Rae-Grant, A.D.; So, Y.T. Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2012, 78, 1009–1015. [Google Scholar] [CrossRef] [PubMed]
- Schmidt, B.; Toyka, K.V.; Kiefer, R.; Full, J.; Hartung, H.-P.; Pollard, J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996, 19, 474–487. [Google Scholar] [CrossRef]
- Kiefer, R.; Kieseier, B.C.; Brück, W.; Hartung, H.P.; Toyka, K.V. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 1998, 121, 469–479. [Google Scholar] [CrossRef] [PubMed]
- Magy, L.; Mathis, S.; Vallat, J.-M. Diagnostic and therapeutic challenges in chronic inflammatory demyelinating polyneuropathy and other immune-mediated neuropathies. Curr. Opin. Crit. Care 2011, 17, 101–105. [Google Scholar] [CrossRef]
- Lunn, M.P.T.; Willison, H.J. Diagnosis and treatment in inflammatory neuropathies. J. Neurol. Neurosurg. Psychiatry 2009, 80, 249–258. [Google Scholar] [CrossRef]
Typical CIDP | CIDP Variants |
---|---|
All of the following: | One of the following, but otherwise as in typical CIDP (tendon reflexes may be normal in unaffected limbs) |
Progressive or relapsing, symmetric, proximal and distal muscle weakness of upper and lower limbs, and sensory involvement of at least two limbs | Distal CIDP: distal sensory loss and muscle weakness predominantly in lower limbs |
Progressing over at least 8 weeks | Multifocal CIDP: sensory loss and muscle weakness in a multifocal pattern, usually asymmetric, upper limb predominant, in more than one limb |
Absent or reduced tendon reflexes in all limbs | Focal CIDP: sensory loss and muscle weakness in only one limb |
Motor CIDP: motor symptoms and signs without sensory involvement | |
Sensory CIDP: sensory symptoms and signs without motor involvement |
No. | First Author’s Name | Year of Publication | Study Type |
---|---|---|---|
1. | Molenaar, DMS [14] | 1998 | Retrospective |
2. | Vital, A [15] | 1999 | Retrospective |
3. | Haq, RU [16] | 2000 | Retrospective |
4. | Bosboom, W.M.J. [17] | 2001 | Case Control |
5. | Vallat, J [18] | 2003 | Case series |
6. | Boukhris, S [19] | 2003 | Retrospective |
7. | Sommer, C [20] | 2005 | Case Control |
8. | Hilton, D [21] | 2007 | Retrospective |
9. | Sommer, C [22] | 2010 | Systematic Review |
10. | Kulkarni, G [23] | 2010 | Retrospective |
11. | Mathis, S [24] | 2011 | Retrospective |
12. | Peltier, A [25] | 2012 | Review |
13. | Mathey, E [26] | 2015 | Review |
14. | Allen, J [27] | 2017 | Retrospective |
15. | Min Xu [28] | 2018 | Case Control |
16. | Berini, S [29] | 2019 | Review |
17. | Nathani, D [30] | 2019 | Systematic Review |
18. | Ikeda, S [31] | 2019 | Retrospective |
19. | Eftimov, F [32] | 2020 | Review |
20. | Luigetti, M [1] | 2020 | Retrospective |
21. | Stino, A [33] | 2020 | Review |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Moise, E.-S.; Bratu, R.M.; Hanganu, A.; Sajin, M. Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—A Systematic Review. Diagnostics 2022, 12, 1691. https://doi.org/10.3390/diagnostics12071691
Moise E-S, Bratu RM, Hanganu A, Sajin M. Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—A Systematic Review. Diagnostics. 2022; 12(7):1691. https://doi.org/10.3390/diagnostics12071691
Chicago/Turabian StyleMoise, Elena-Sonia, Razvan Matei Bratu, Andreea Hanganu, and Maria Sajin. 2022. "Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—A Systematic Review" Diagnostics 12, no. 7: 1691. https://doi.org/10.3390/diagnostics12071691
APA StyleMoise, E.-S., Bratu, R. M., Hanganu, A., & Sajin, M. (2022). Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—A Systematic Review. Diagnostics, 12(7), 1691. https://doi.org/10.3390/diagnostics12071691